Insigneo Advisory Services’s Novo Nordisk NVO Stock Holding History

Insigneo Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$385K	Sell	10,471 -6,484	-38%	-$307K	0.03%	438
2025 Q4	$863K	Sell	16,955 -8,512	-33%	-$435K	0.06%	240
2025 Q3	$1.41M	Buy	25,467 +1,368	+6%	+$80.1K	0.1%	164
2025 Q2	$1.66M	Buy	24,099 +14,977	+164%	+$1.02M	0.14%	129
2025 Q1	$633K	Sell	9,122 -3,237	-26%	-$267K	0.07%	244
2024 Q4	$1.06M	Buy	12,359 +412	+3%	+$44.6K	0.11%	157
2024 Q3	$1.42M	Buy	11,947 +1,254	+12%	+$167K	0.14%	140
2024 Q2	$1.35M	Buy	10,693 +108	+1%	+$14.3K	0.15%	133
2024 Q1	$1.37M	Buy	10,585 +5,122	+94%	+$610K	0.16%	121
2023 Q4	$565K	Buy	5,463 +859	+19%	+$84.9K	0.08%	221
2023 Q3	$419K	Buy	4,604 +238	+5%	+$21K	0.09%	220
2023 Q2	$353K	Buy	4,366 +304	+7%	+$24.8K	0.07%	251
2023 Q1	$326K	Buy	4,062 +154	+4%	+$10.9K	0.1%	196
2022 Q4	$264K	Buy	+3,908	New	+$229K	0.1%	209

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Insigneo Advisory Services's NVO Position: Q1 2026 in Review

Insigneo Advisory Services reduced its Novo Nordisk (NVO) stake by 38% in Q1 2026, selling an estimated $307K and leaving 10,471 shares worth $385K. The position accounts for 0.03% of the portfolio, ranked #438.

Insigneo Advisory Services first reported a position in NVO in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.66M in Q2 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Insigneo Advisory Services held 10,471 shares of Novo Nordisk worth $385K as of Q1 2026.
Insigneo Advisory Services sold 6,484 Novo Nordisk shares in Q1 2026, an estimated $307K.
Novo Nordisk made up 0.03% of Insigneo Advisory Services's portfolio in Q1 2026, its #438 holding.
Insigneo Advisory Services first reported a position in Novo Nordisk in Q4 2022 and has held it in 14 quarters since.
Insigneo Advisory Services's Novo Nordisk position peaked at $1.66M in Q2 2025.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Insigneo Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.